| IV-050 Stijn van Beek Population pharmacokinetic analysis of elafibranor and metabolite GFT1007 to support exposure-response characterization and dose selection in patients with primary biliary cholangitis Thursday 15:00-16:30 |
| IV-050 Stijn van Beek Population pharmacokinetic analysis of elafibranor and metabolite GFT1007 to support exposure-response characterization and dose selection in patients with primary biliary cholangitis Thursday 15:00-16:30 |